The anti-AD effects of trazodone were reported by the de Oliveira research group, which demonstrated that chronic treatment with trazodone reduced the activation of cellular components that are key to neuroinflammation and tau pathology in rTg4510 mice when tau aggregation is observed [121]. Here, MAPT is linked to Alzheimer disease.